# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044841
Filing Date
2024-11-12
Accepted
2024-11-12 17:16:28
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1106870
2 |  | ex10-10.htm | EX-10.10 | 329609
3 |  | ex10-11.htm | EX-10.11 | 22916
4 |  | ex31-1.htm | EX-31.1 | 12544
5 |  | ex31-2.htm | EX-31.2 | 12591
6 |  | ex32-1.htm | EX-32.1 | 6985
7 |  | ex32-2.htm | EX-32.2 | 6976
8 |  | form10-q_001.jpg | GRAPHIC | 2383
| Complete submission text file | 0001493152-24-044841.txt |  | 6724857

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | erna-20240930.xsd | EX-101.SCH | 56656
10 | XBRL CALCULATION FILE | erna-20240930_cal.xml | EX-101.CAL | 70835
11 | XBRL DEFINITION FILE | erna-20240930_def.xml | EX-101.DEF | 249476
12 | XBRL LABEL FILE | erna-20240930_lab.xml | EX-101.LAB | 468865
13 | XBRL PRESENTATION FILE | erna-20240930_pre.xml | EX-101.PRE | 386953
83 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 777880

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 241449872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)